ES2645019T3 - Descubrimiento innovador de composiciones terapéuticas, de diagnóstico y de anticuerpos relacionadas con fragmentos de proteínas de triptofanil-ARNt sintetasas - Google Patents

Info

Publication number

ES2645019T3

ES2645019T3 ES11831608.2T ES11831608T ES2645019T3 ES 2645019 T3 ES2645019 T3 ES 2645019T3 ES 11831608 T ES11831608 T ES 11831608T ES 2645019 T3 ES2645019 T3 ES 2645019T3

Authority

ES

Spain

Prior art keywords

aars

protein

know

polypeptide

sequence

Prior art date

2010-10-06

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Active

Links

• Espacenet
• Global Dossier
• Discuss

• 239000000203 mixture Substances 0.000 title claims abstract description 84
• 230000001225 therapeutic effect Effects 0.000 title claims abstract description 33
• 239000012634 fragment Substances 0.000 title description 209
• 108090000364 Ligases Proteins 0.000 title description 18
• 102000003960 Ligases Human genes 0.000 title description 17
• 102000052866 Amino Acyl-tRNA Synthetases Human genes 0.000 claims abstract description 459
• 108700028939 Amino Acyl-tRNA Synthetases Proteins 0.000 claims abstract description 459
• 108090000623 proteins and genes Proteins 0.000 claims abstract description 373
• 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 360
• 102000004169 proteins and genes Human genes 0.000 claims abstract description 336
• 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 328
• 229920001184 polypeptide Polymers 0.000 claims abstract description 297
• 150000001413 amino acids Chemical class 0.000 claims abstract description 125
• 230000000694 effects Effects 0.000 claims abstract description 125
• 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 44
• 239000002158 endotoxin Substances 0.000 claims abstract description 34
• 230000008622 extracellular signaling Effects 0.000 claims abstract description 8
• 238000006467 substitution reaction Methods 0.000 claims description 28
• 238000012217 deletion Methods 0.000 claims description 12
• 230000037430 deletion Effects 0.000 claims description 12
• 238000011282 treatment Methods 0.000 claims description 10
• 239000008194 pharmaceutical composition Substances 0.000 claims description 7
• 208000027866 inflammatory disease Diseases 0.000 claims description 6
• 230000002757 inflammatory effect Effects 0.000 claims description 3
• 208000024172 Cardiovascular disease Diseases 0.000 claims description 2
• 201000001320 Atherosclerosis Diseases 0.000 claims 2
• 208000019693 Lung disease Diseases 0.000 claims 2
• 208000011623 Obstructive Lung disease Diseases 0.000 claims 2
• 208000002815 pulmonary hypertension Diseases 0.000 claims 2
• 208000019553 vascular disease Diseases 0.000 claims 2
• 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
• 208000035150 Hypercholesterolemia Diseases 0.000 claims 1
• 208000031226 Hyperlipidaemia Diseases 0.000 claims 1
• 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 claims 1
• 208000001145 Metabolic Syndrome Diseases 0.000 claims 1
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 1
• 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims 1
• 208000006673 asthma Diseases 0.000 claims 1
• 230000005784 autoimmunity Effects 0.000 claims 1
• 208000036971 interstitial lung disease 2 Diseases 0.000 claims 1
• 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 1
• 235000018102 proteins Nutrition 0.000 description 319
• 210000004027 cell Anatomy 0.000 description 169
• 235000001014 amino acid Nutrition 0.000 description 131
• 229940024606 amino acid Drugs 0.000 description 124
• 238000000034 method Methods 0.000 description 123
• 241000699666 Mus <mouse, genus> Species 0.000 description 115
• 102000040430 polynucleotide Human genes 0.000 description 107
• 108091033319 polynucleotide Proteins 0.000 description 107
• 239000002157 polynucleotide Substances 0.000 description 107
• 241000282414 Homo sapiens Species 0.000 description 92
• 230000027455 binding Effects 0.000 description 89
• 108020004414 DNA Proteins 0.000 description 65
• 125000003729 nucleotide group Chemical group 0.000 description 48
• 150000007523 nucleic acids Chemical class 0.000 description 47
• 230000014509 gene expression Effects 0.000 description 46
• 239000002773 nucleotide Substances 0.000 description 46
• 150000001875 compounds Chemical class 0.000 description 45
• 239000013598 vector Substances 0.000 description 42
• 239000003795 chemical substances by application Substances 0.000 description 41
• 239000013615 primer Substances 0.000 description 40
• 241000894007 species Species 0.000 description 40
• 239000000523 sample Substances 0.000 description 37
• 239000004365 Protease Substances 0.000 description 35
• 108091034117 Oligonucleotide Proteins 0.000 description 34
• 102000035195 Peptidases Human genes 0.000 description 34
• 108091005804 Peptidases Proteins 0.000 description 34
• 230000004071 biological effect Effects 0.000 description 33
• 102000039446 nucleic acids Human genes 0.000 description 33
• 108020004707 nucleic acids Proteins 0.000 description 33
• 239000011230 binding agent Substances 0.000 description 32
• 238000004949 mass spectrometry Methods 0.000 description 29
• 230000000875 corresponding effect Effects 0.000 description 26
• 238000003556 assay Methods 0.000 description 23
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 23
• 125000000539 amino acid group Chemical group 0.000 description 22
• 239000000427 antigen Substances 0.000 description 22
• 108091007433 antigens Proteins 0.000 description 21
• 102000036639 antigens Human genes 0.000 description 21
• 230000014616 translation Effects 0.000 description 21
• 238000009396 hybridization Methods 0.000 description 20
• 238000004519 manufacturing process Methods 0.000 description 20
• 239000000047 product Substances 0.000 description 20
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 19
• 238000000338 in vitro Methods 0.000 description 19
• 238000012360 testing method Methods 0.000 description 19
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 18
• 201000010099 disease Diseases 0.000 description 18
• 239000012528 membrane Substances 0.000 description 18
• 108010006303 Carboxypeptidases Proteins 0.000 description 17
• 102000005367 Carboxypeptidases Human genes 0.000 description 17
• -1 desmosin Chemical compound 0.000 description 17
• 239000013604 expression vector Substances 0.000 description 17
• 239000000126 substance Substances 0.000 description 17
• 230000000295 complement effect Effects 0.000 description 16
• 108020004999 messenger RNA Proteins 0.000 description 16
• 235000019419 proteases Nutrition 0.000 description 16
• 238000000746 purification Methods 0.000 description 16
• 102000004190 Enzymes Human genes 0.000 description 15
• 238000005516 engineering process Methods 0.000 description 15
• 229940088598 enzyme Drugs 0.000 description 15
• 102000037865 fusion proteins Human genes 0.000 description 15
• 108020001507 fusion proteins Proteins 0.000 description 15
• 238000001727 in vivo Methods 0.000 description 15
• 239000002245 particle Substances 0.000 description 15
• 230000002797 proteolythic effect Effects 0.000 description 15
• 150000003384 small molecules Chemical class 0.000 description 15
• 108090000790 Enzymes Proteins 0.000 description 14
• ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 14
• 102000005962 receptors Human genes 0.000 description 14
• 108020003175 receptors Proteins 0.000 description 14
• 210000001519 tissue Anatomy 0.000 description 14
• 238000013519 translation Methods 0.000 description 14
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 13
• 238000004458 analytical method Methods 0.000 description 13
• 230000001413 cellular effect Effects 0.000 description 13
• 239000003153 chemical reaction reagent Substances 0.000 description 13
• 238000001514 detection method Methods 0.000 description 13
• 235000014304 histidine Nutrition 0.000 description 13
• 229920001223 polyethylene glycol Polymers 0.000 description 13
• 229920000642 polymer Polymers 0.000 description 13
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 12
• 230000015572 biosynthetic process Effects 0.000 description 12
• 239000003814 drug Substances 0.000 description 12
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 12
• 230000003993 interaction Effects 0.000 description 12
• 230000004048 modification Effects 0.000 description 12
• 238000012986 modification Methods 0.000 description 12
• 230000035897 transcription Effects 0.000 description 12
• 238000013518 transcription Methods 0.000 description 12
• 101000640990 Arabidopsis thaliana Tryptophan-tRNA ligase, chloroplastic/mitochondrial Proteins 0.000 description 11
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 11
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 11
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 11
• 108091028043 Nucleic acid sequence Proteins 0.000 description 11
• 102000002501 Tryptophan-tRNA Ligase Human genes 0.000 description 11
• 238000007792 addition Methods 0.000 description 11
• 239000000556 agonist Substances 0.000 description 11
• 239000002585 base Substances 0.000 description 11
• 231100000673 dose–response relationship Toxicity 0.000 description 11
• 229940079593 drug Drugs 0.000 description 11
• 239000002609 medium Substances 0.000 description 11
• 238000012545 processing Methods 0.000 description 11
• 238000005406 washing Methods 0.000 description 11
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 10
• 108060003951 Immunoglobulin Proteins 0.000 description 10
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 10
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 10
• 241000700605 Viruses Species 0.000 description 10
• 210000004899 c-terminal region Anatomy 0.000 description 10
• 230000004927 fusion Effects 0.000 description 10
• 102000018358 immunoglobulin Human genes 0.000 description 10
• 230000001177 retroviral effect Effects 0.000 description 10
• 238000003786 synthesis reaction Methods 0.000 description 10
• 241000894006 Bacteria Species 0.000 description 9
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 9
• 108020004705 Codon Proteins 0.000 description 9
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 9
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 9
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 9
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 9
• 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 9
• 229940098773 bovine serum albumin Drugs 0.000 description 9
• 239000000975 dye Substances 0.000 description 9
• 230000006870 function Effects 0.000 description 9
• 230000001404 mediated effect Effects 0.000 description 9
• 239000000816 peptidomimetic Substances 0.000 description 9
• 239000002987 primer (paints) Substances 0.000 description 9
• 230000008569 process Effects 0.000 description 9
• 230000017854 proteolysis Effects 0.000 description 9
• 238000011160 research Methods 0.000 description 9
• 239000002904 solvent Substances 0.000 description 9
• 108091026890 Coding region Proteins 0.000 description 8
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 8
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 8
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 8
• 210000001744 T-lymphocyte Anatomy 0.000 description 8
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 8
• 239000004473 Threonine Substances 0.000 description 8
• 230000001580 bacterial effect Effects 0.000 description 8
• 238000007876 drug discovery Methods 0.000 description 8
• 235000013930 proline Nutrition 0.000 description 8
• 235000004400 serine Nutrition 0.000 description 8
• 210000002966 serum Anatomy 0.000 description 8
• 239000000758 substrate Substances 0.000 description 8
• 235000008521 threonine Nutrition 0.000 description 8
• 239000004475 Arginine Substances 0.000 description 7
• 108020004635 Complementary DNA Proteins 0.000 description 7
• 241000588724 Escherichia coli Species 0.000 description 7
• 241000282412 Homo Species 0.000 description 7
• XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 7
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 7
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 7
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 7
• 239000004472 Lysine Substances 0.000 description 7
• 241001465754 Metazoa Species 0.000 description 7
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 7
• 230000002776 aggregation Effects 0.000 description 7
• 238000004220 aggregation Methods 0.000 description 7
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 7
• 235000009697 arginine Nutrition 0.000 description 7
• 238000010804 cDNA synthesis Methods 0.000 description 7
• 229910052799 carbon Inorganic materials 0.000 description 7
• 230000008859 change Effects 0.000 description 7
• 238000012512 characterization method Methods 0.000 description 7
• 238000006243 chemical reaction Methods 0.000 description 7
• 239000002299 complementary DNA Substances 0.000 description 7
• 239000013078 crystal Substances 0.000 description 7
• 238000012350 deep sequencing Methods 0.000 description 7
• 235000013922 glutamic acid Nutrition 0.000 description 7
• 239000004220 glutamic acid Substances 0.000 description 7
• 238000003780 insertion Methods 0.000 description 7
• 230000037431 insertion Effects 0.000 description 7
• 239000003446 ligand Substances 0.000 description 7
• 235000018977 lysine Nutrition 0.000 description 7
• 239000003550 marker Substances 0.000 description 7
• 239000011159 matrix material Substances 0.000 description 7
• 229910052757 nitrogen Inorganic materials 0.000 description 7
• 239000013612 plasmid Substances 0.000 description 7
• 239000002096 quantum dot Substances 0.000 description 7
• 230000004044 response Effects 0.000 description 7
• 238000012552 review Methods 0.000 description 7
• 230000028327 secretion Effects 0.000 description 7
• 230000005945 translocation Effects 0.000 description 7
• 102000000844 Cell Surface Receptors Human genes 0.000 description 6
• 108010001857 Cell Surface Receptors Proteins 0.000 description 6
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 6
• 239000004471 Glycine Substances 0.000 description 6
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 6
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 6
• 108010079855 Peptide Aptamers Proteins 0.000 description 6
• 102000001708 Protein Isoforms Human genes 0.000 description 6
• 108010029485 Protein Isoforms Proteins 0.000 description 6
• 108091081024 Start codon Proteins 0.000 description 6
• 230000003321 amplification Effects 0.000 description 6
• 230000000692 anti-sense effect Effects 0.000 description 6
• 238000013459 approach Methods 0.000 description 6
• 238000004166 bioassay Methods 0.000 description 6
• 230000024245 cell differentiation Effects 0.000 description 6
• 238000010367 cloning Methods 0.000 description 6
• 239000000306 component Substances 0.000 description 6
• 230000005847 immunogenicity Effects 0.000 description 6
• 238000003199 nucleic acid amplification method Methods 0.000 description 6
• 230000000144 pharmacologic effect Effects 0.000 description 6
• 150000003839 salts Chemical class 0.000 description 6
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 5
• 238000002965 ELISA Methods 0.000 description 5
• 241000196324 Embryophyta Species 0.000 description 5
• 108010070675 Glutathione transferase Proteins 0.000 description 5
• 102100029100 Hematopoietic prostaglandin D synthase Human genes 0.000 description 5
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 5
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 5
• 206010061218 Inflammation Diseases 0.000 description 5
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 5
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 5
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 5
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 5
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 5
• 108091027974 Mature messenger RNA Proteins 0.000 description 5
• 108020004511 Recombinant DNA Proteins 0.000 description 5
• 241000283984 Rodentia Species 0.000 description 5
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 5
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical group [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 5
• QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
• 239000002253 acid Substances 0.000 description 5
• 235000004279 alanine Nutrition 0.000 description 5
• 125000000266 alpha-aminoacyl group Chemical group 0.000 description 5
• 230000006229 amino acid addition Effects 0.000 description 5
• 239000005557 antagonist Substances 0.000 description 5
• 125000003118 aryl group Chemical group 0.000 description 5
• 235000009582 asparagine Nutrition 0.000 description 5
• 229960001230 asparagine Drugs 0.000 description 5
• 235000003704 aspartic acid Nutrition 0.000 description 5
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 5
• 238000004422 calculation algorithm Methods 0.000 description 5
• 238000004113 cell culture Methods 0.000 description 5
• 230000030833 cell death Effects 0.000 description 5
• 238000002659 cell therapy Methods 0.000 description 5
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 5
• 235000018417 cysteine Nutrition 0.000 description 5
• 208000035475 disorder Diseases 0.000 description 5
• 230000009368 gene silencing by RNA Effects 0.000 description 5
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 5
• 235000004554 glutamine Nutrition 0.000 description 5
• 238000004128 high performance liquid chromatography Methods 0.000 description 5
• 230000004054 inflammatory process Effects 0.000 description 5
• 229960000310 isoleucine Drugs 0.000 description 5
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 5
• 229920006008 lipopolysaccharide Polymers 0.000 description 5
• 210000004962 mammalian cell Anatomy 0.000 description 5
• 239000000463 material Substances 0.000 description 5
• 230000007246 mechanism Effects 0.000 description 5
• 229930182817 methionine Natural products 0.000 description 5
• 238000002703 mutagenesis Methods 0.000 description 5
• 231100000350 mutagenesis Toxicity 0.000 description 5
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 5
• 238000003752 polymerase chain reaction Methods 0.000 description 5
• 230000001105 regulatory effect Effects 0.000 description 5
• 239000000243 solution Substances 0.000 description 5
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 5
• 235000002374 tyrosine Nutrition 0.000 description 5
• 239000004474 valine Substances 0.000 description 5
• 229910052725 zinc Inorganic materials 0.000 description 5
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
• 108091023037 Aptamer Proteins 0.000 description 4
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 4
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 4
• 241000124008 Mammalia Species 0.000 description 4
• 102000005741 Metalloproteases Human genes 0.000 description 4
• 108010006035 Metalloproteases Proteins 0.000 description 4
• PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
• 102000016387 Pancreatic elastase Human genes 0.000 description 4
• 108010067372 Pancreatic elastase Proteins 0.000 description 4
• 108010043958 Peptoids Proteins 0.000 description 4
• 102100026126 Proline-tRNA ligase Human genes 0.000 description 4
• 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 4
• 238000012300 Sequence Analysis Methods 0.000 description 4
• 102000012479 Serine Proteases Human genes 0.000 description 4
• 108010022999 Serine Proteases Proteins 0.000 description 4
• 230000004075 alteration Effects 0.000 description 4
• 230000033115 angiogenesis Effects 0.000 description 4
• 230000006907 apoptotic process Effects 0.000 description 4
• 239000007864 aqueous solution Substances 0.000 description 4
• 150000001720 carbohydrates Chemical class 0.000 description 4
• 235000014633 carbohydrates Nutrition 0.000 description 4
• 230000015556 catabolic process Effects 0.000 description 4
• 238000000423 cell based assay Methods 0.000 description 4
• 210000000170 cell membrane Anatomy 0.000 description 4
• 230000004663 cell proliferation Effects 0.000 description 4
• 230000005754 cellular signaling Effects 0.000 description 4
• 108010057085 cytokine receptors Proteins 0.000 description 4
• 102000003675 cytokine receptors Human genes 0.000 description 4
• 230000001086 cytosolic effect Effects 0.000 description 4
• 230000034994 death Effects 0.000 description 4
• 238000006731 degradation reaction Methods 0.000 description 4
• 239000003623 enhancer Substances 0.000 description 4
• 230000002255 enzymatic effect Effects 0.000 description 4
• 239000007850 fluorescent dye Substances 0.000 description 4
• 238000001415 gene therapy Methods 0.000 description 4
• 230000002068 genetic effect Effects 0.000 description 4
• RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
• 230000001965 increasing effect Effects 0.000 description 4
• 230000001939 inductive effect Effects 0.000 description 4
• 210000003292 kidney cell Anatomy 0.000 description 4
• 150000002632 lipids Chemical class 0.000 description 4
• 238000002493 microarray Methods 0.000 description 4
• 238000010369 molecular cloning Methods 0.000 description 4
• 239000000178 monomer Substances 0.000 description 4
• 230000035772 mutation Effects 0.000 description 4
• 239000002105 nanoparticle Substances 0.000 description 4
• 210000000056 organ Anatomy 0.000 description 4
• 239000012071 phase Substances 0.000 description 4
• 239000002243 precursor Substances 0.000 description 4
• 238000002360 preparation method Methods 0.000 description 4
• 235000019833 protease Nutrition 0.000 description 4
• 230000002441 reversible effect Effects 0.000 description 4
• 238000000926 separation method Methods 0.000 description 4
• 238000012163 sequencing technique Methods 0.000 description 4
• 208000024891 symptom Diseases 0.000 description 4
• 230000009897 systematic effect Effects 0.000 description 4
• 230000001052 transient effect Effects 0.000 description 4
• 210000002845 virion Anatomy 0.000 description 4
• 230000003612 virological effect Effects 0.000 description 4
• 239000011701 zinc Substances 0.000 description 4
• JTTIOYHBNXDJOD-UHFFFAOYSA-N 2,4,6-triaminopyrimidine Chemical compound NC1=CC(N)=NC(N)=N1 JTTIOYHBNXDJOD-UHFFFAOYSA-N 0.000 description 3
• 102000035101 Aspartic proteases Human genes 0.000 description 3
• 108091005502 Aspartic proteases Proteins 0.000 description 3
• 108010032088 Calpain Proteins 0.000 description 3
• 102000007590 Calpain Human genes 0.000 description 3
• 108090000317 Chymotrypsin Proteins 0.000 description 3
• 102000005927 Cysteine Proteases Human genes 0.000 description 3
• 108010005843 Cysteine Proteases Proteins 0.000 description 3
• 102000053602 DNA Human genes 0.000 description 3
• 238000012286 ELISA Assay Methods 0.000 description 3
• 108700024394 Exon Proteins 0.000 description 3
• 230000010697 Gene Transcription Modulation Effects 0.000 description 3
• 241000238631 Hexapoda Species 0.000 description 3
• 101001027128 Homo sapiens Fibronectin Proteins 0.000 description 3
• 101000724418 Homo sapiens Neutral amino acid transporter B(0) Proteins 0.000 description 3
• 241000725303 Human immunodeficiency virus Species 0.000 description 3
• 108010004098 Leucyl aminopeptidase Proteins 0.000 description 3
• 102000002704 Leucyl aminopeptidase Human genes 0.000 description 3
• 102100028267 Neutral amino acid transporter B(0) Human genes 0.000 description 3
• 108090000284 Pepsin A Proteins 0.000 description 3
• 102000057297 Pepsin A Human genes 0.000 description 3
• 101710182846 Polyhedrin Proteins 0.000 description 3
• 108010076504 Protein Sorting Signals Proteins 0.000 description 3
• 108091028664 Ribonucleotide Proteins 0.000 description 3
• 241000714474 Rous sarcoma virus Species 0.000 description 3
• BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
• 108090000787 Subtilisin Proteins 0.000 description 3
• 108090001109 Thermolysin Proteins 0.000 description 3
• 241000723873 Tobacco mosaic virus Species 0.000 description 3
• 102000004142 Trypsin Human genes 0.000 description 3
• 108090000631 Trypsin Proteins 0.000 description 3
• 230000001594 aberrant effect Effects 0.000 description 3
• 150000007513 acids Chemical class 0.000 description 3
• DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 3
• 230000002411 adverse Effects 0.000 description 3
• 150000001408 amides Chemical class 0.000 description 3
• 210000004102 animal cell Anatomy 0.000 description 3
• 239000000074 antisense oligonucleotide Substances 0.000 description 3
• 238000012230 antisense oligonucleotides Methods 0.000 description 3
• 239000012736 aqueous medium Substances 0.000 description 3
• 238000007622 bioinformatic analysis Methods 0.000 description 3
• 210000004556 brain Anatomy 0.000 description 3
• 239000000872 buffer Substances 0.000 description 3
• 238000006555 catalytic reaction Methods 0.000 description 3
• 230000012292 cell migration Effects 0.000 description 3
• 238000004587 chromatography analysis Methods 0.000 description 3
• 229960002376 chymotrypsin Drugs 0.000 description 3
• 230000008878 coupling Effects 0.000 description 3
• 238000010168 coupling process Methods 0.000 description 3
• 238000005859 coupling reaction Methods 0.000 description 3
• 125000004122 cyclic group Chemical group 0.000 description 3
• 230000016396 cytokine production Effects 0.000 description 3
• 230000003013 cytotoxicity Effects 0.000 description 3
• 231100000135 cytotoxicity Toxicity 0.000 description 3
• 239000000539 dimer Substances 0.000 description 3
• 210000003527 eukaryotic cell Anatomy 0.000 description 3
• 239000000284 extract Substances 0.000 description 3
• 230000002349 favourable effect Effects 0.000 description 3
• GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 3
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
• 229910052737 gold Inorganic materials 0.000 description 3
• 239000010931 gold Substances 0.000 description 3
• 230000012010 growth Effects 0.000 description 3
• 230000006872 improvement Effects 0.000 description 3
• 208000015181 infectious disease Diseases 0.000 description 3
• 230000009878 intermolecular interaction Effects 0.000 description 3
• 150000002500 ions Chemical class 0.000 description 3
• 238000002955 isolation Methods 0.000 description 3
• 210000003734 kidney Anatomy 0.000 description 3
• 230000000670 limiting effect Effects 0.000 description 3
• 125000005647 linker group Chemical group 0.000 description 3
• 239000002502 liposome Substances 0.000 description 3
• 210000004698 lymphocyte Anatomy 0.000 description 3
• 210000002540 macrophage Anatomy 0.000 description 3
• 230000007935 neutral effect Effects 0.000 description 3
• 108091008104 nucleic acid aptamers Proteins 0.000 description 3
• 238000004806 packaging method and process Methods 0.000 description 3
• 230000006320 pegylation Effects 0.000 description 3
• 229940111202 pepsin Drugs 0.000 description 3
• 238000010647 peptide synthesis reaction Methods 0.000 description 3
• 230000004481 post-translational protein modification Effects 0.000 description 3
• 230000001323 posttranslational effect Effects 0.000 description 3
• 238000001243 protein synthesis Methods 0.000 description 3
• 230000009467 reduction Effects 0.000 description 3
• 238000002271 resection Methods 0.000 description 3
• 239000002336 ribonucleotide Substances 0.000 description 3
• 125000002652 ribonucleotide group Chemical group 0.000 description 3
• 229910052709 silver Inorganic materials 0.000 description 3
• 239000004332 silver Substances 0.000 description 3
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
• 230000009870 specific binding Effects 0.000 description 3
• 238000002560 therapeutic procedure Methods 0.000 description 3
• 230000009466 transformation Effects 0.000 description 3
• 239000012588 trypsin Substances 0.000 description 3
• 241000701161 unidentified adenovirus Species 0.000 description 3
• 241001430294 unidentified retrovirus Species 0.000 description 3
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
• BAAVRTJSLCSMNM-CMOCDZPBSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-4-carboxybutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]pentanedioic acid Chemical compound C([C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C1=CC=C(O)C=C1 BAAVRTJSLCSMNM-CMOCDZPBSA-N 0.000 description 2
• 108010052418 (N-(2-((4-((2-((4-(9-acridinylamino)phenyl)amino)-2-oxoethyl)amino)-4-oxobutyl)amino)-1-(1H-imidazol-4-ylmethyl)-1-oxoethyl)-6-(((-2-aminoethyl)amino)methyl)-2-pyridinecarboxamidato) iron(1+) Proteins 0.000 description 2
• WQZIDRAQTRIQDX-UHFFFAOYSA-N 6-carboxy-x-rhodamine Chemical compound OC(=O)C1=CC=C(C([O-])=O)C=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 WQZIDRAQTRIQDX-UHFFFAOYSA-N 0.000 description 2
• BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 2
• 102000006268 Alanine-tRNA ligase Human genes 0.000 description 2
• 108010058060 Alanine-tRNA ligase Proteins 0.000 description 2
• IKYJCHYORFJFRR-UHFFFAOYSA-N Alexa Fluor 350 Chemical compound O=C1OC=2C=C(N)C(S(O)(=O)=O)=CC=2C(C)=C1CC(=O)ON1C(=O)CCC1=O IKYJCHYORFJFRR-UHFFFAOYSA-N 0.000 description 2
• WHVNXSBKJGAXKU-UHFFFAOYSA-N Alexa Fluor 532 Chemical compound [H+].[H+].CC1(C)C(C)NC(C(=C2OC3=C(C=4C(C(C(C)N=4)(C)C)=CC3=3)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=C2C=3C(C=C1)=CC=C1C(=O)ON1C(=O)CCC1=O WHVNXSBKJGAXKU-UHFFFAOYSA-N 0.000 description 2
• ZAINTDRBUHCDPZ-UHFFFAOYSA-M Alexa Fluor 546 Chemical compound [H+].[Na+].CC1CC(C)(C)NC(C(=C2OC3=C(C4=NC(C)(C)CC(C)C4=CC3=3)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=C2C=3C(C(=C(Cl)C=1Cl)C(O)=O)=C(Cl)C=1SCC(=O)NCCCCCC(=O)ON1C(=O)CCC1=O ZAINTDRBUHCDPZ-UHFFFAOYSA-M 0.000 description 2
• 102000002249 Arginine-tRNA Ligase Human genes 0.000 description 2
• 108010014885 Arginine-tRNA ligase Proteins 0.000 description 2
• 102000003924 Asparagine-tRNA ligases Human genes 0.000 description 2
• 108090000314 Asparagine-tRNA ligases Proteins 0.000 description 2
• 108010065272 Aspartate-tRNA ligase Proteins 0.000 description 2
• 102100026198 Aspartate-tRNA ligase, mitochondrial Human genes 0.000 description 2
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
• 241000201370 Autographa californica nucleopolyhedrovirus Species 0.000 description 2
• 208000023275 Autoimmune disease Diseases 0.000 description 2
• 108090001008 Avidin Proteins 0.000 description 2
• 206010006187 Breast cancer Diseases 0.000 description 2
• 108010004032 Bromelains Proteins 0.000 description 2
• 125000001433 C-terminal amino-acid group Chemical group 0.000 description 2
• 102000014914 Carrier Proteins Human genes 0.000 description 2
• 102000005600 Cathepsins Human genes 0.000 description 2
• 108010084457 Cathepsins Proteins 0.000 description 2
• 241000282693 Cercopithecidae Species 0.000 description 2
• 108010047041 Complementarity Determining Regions Proteins 0.000 description 2
• 108091035707 Consensus sequence Proteins 0.000 description 2
• 102000004403 Cysteine-tRNA ligases Human genes 0.000 description 2
• 108090000918 Cysteine-tRNA ligases Proteins 0.000 description 2
• SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 2
• 241001635598 Enicostema Species 0.000 description 2
• 108010074860 Factor Xa Proteins 0.000 description 2
• 102100037362 Fibronectin Human genes 0.000 description 2
• 108010015514 Glutamate-tRNA ligase Proteins 0.000 description 2
• 102100024977 Glutamine-tRNA ligase Human genes 0.000 description 2
• 108010024636 Glutathione Proteins 0.000 description 2
• 108010051724 Glycine-tRNA Ligase Proteins 0.000 description 2
• 102000019220 Glycyl-tRNA synthetases Human genes 0.000 description 2
• 102000001398 Granzyme Human genes 0.000 description 2
• 108060005986 Granzyme Proteins 0.000 description 2
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
• 102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
• NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
• 102000006354 HLA-DR Antigens Human genes 0.000 description 2
• 108010058597 HLA-DR Antigens Proteins 0.000 description 2
• 241000713858 Harvey murine sarcoma virus Species 0.000 description 2
• 108010093488 His-His-His-His-His-His Proteins 0.000 description 2
• 101100479034 Homo sapiens AARS1 gene Proteins 0.000 description 2
• 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 2
• 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 2
• SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
• 102100034349 Integrase Human genes 0.000 description 2
• 108091092195 Intron Proteins 0.000 description 2
• 102000029793 Isoleucine-tRNA ligase Human genes 0.000 description 2
• 101710176147 Isoleucine-tRNA ligase, cytoplasmic Proteins 0.000 description 2
• 239000000232 Lipid Bilayer Substances 0.000 description 2
• 239000005089 Luciferase Substances 0.000 description 2
• 108060001084 Luciferase Proteins 0.000 description 2
• 102000017737 Lysine-tRNA Ligase Human genes 0.000 description 2
• 108010092041 Lysine-tRNA Ligase Proteins 0.000 description 2
• 108010003060 Methionine-tRNA ligase Proteins 0.000 description 2
• 102000000362 Methionyl-tRNA synthetases Human genes 0.000 description 2
• 241000713869 Moloney murine leukemia virus Species 0.000 description 2
• 241001529936 Murinae Species 0.000 description 2
• 241000699670 Mus sp. Species 0.000 description 2
• 206010028980 Neoplasm Diseases 0.000 description 2
• 108090000526 Papain Proteins 0.000 description 2
• 102000002798 Phenylalanine-tRNA Ligase Human genes 0.000 description 2
• 108010004478 Phenylalanine-tRNA Ligase Proteins 0.000 description 2
• 239000004372 Polyvinyl alcohol Substances 0.000 description 2
• 241000288906 Primates Species 0.000 description 2
• 101710149031 Probable isoleucine-tRNA ligase, cytoplasmic Proteins 0.000 description 2
• 101710146427 Probable tyrosine-tRNA ligase, cytoplasmic Proteins 0.000 description 2
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
• 108090000783 Renin Proteins 0.000 description 2
• 102100028255 Renin Human genes 0.000 description 2
• 108010030161 Serine-tRNA ligase Proteins 0.000 description 2
• 102100040516 Serine-tRNA ligase, cytoplasmic Human genes 0.000 description 2
• 108010003723 Single-Domain Antibodies Proteins 0.000 description 2
• 241000256251 Spodoptera frugiperda Species 0.000 description 2
• 102000001618 Threonine-tRNA Ligase Human genes 0.000 description 2
• 108010029287 Threonine-tRNA ligase Proteins 0.000 description 2
• 108090000190 Thrombin Proteins 0.000 description 2
• 241000255985 Trichoplusia Species 0.000 description 2
• 102000018378 Tyrosine-tRNA ligase Human genes 0.000 description 2
• 101710107268 Tyrosine-tRNA ligase, mitochondrial Proteins 0.000 description 2
• 230000021736 acetylation Effects 0.000 description 2
• 238000006640 acetylation reaction Methods 0.000 description 2
• 230000002378 acidificating effect Effects 0.000 description 2
• 230000009471 action Effects 0.000 description 2
• 230000004913 activation Effects 0.000 description 2
• OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
• 238000012382 advanced drug delivery Methods 0.000 description 2
• 238000001261 affinity purification Methods 0.000 description 2
• 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 2
• 150000001412 amines Chemical class 0.000 description 2
• 238000013103 analytical ultracentrifugation Methods 0.000 description 2
• 238000010171 animal model Methods 0.000 description 2
• 230000003042 antagnostic effect Effects 0.000 description 2
• 239000003242 anti bacterial agent Substances 0.000 description 2
• 210000000612 antigen-presenting cell Anatomy 0.000 description 2
• RASZIXQTZOARSV-BDPUVYQTSA-N astacin Chemical compound CC=1C(=O)C(=O)CC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)C(=O)CC1(C)C RASZIXQTZOARSV-BDPUVYQTSA-N 0.000 description 2
• 230000008901 benefit Effects 0.000 description 2
• 108091008324 binding proteins Proteins 0.000 description 2
• 238000010256 biochemical assay Methods 0.000 description 2
• 239000013060 biological fluid Substances 0.000 description 2
• 230000008827 biological function Effects 0.000 description 2
• 230000008236 biological pathway Effects 0.000 description 2
• 235000020958 biotin Nutrition 0.000 description 2
• 239000011616 biotin Substances 0.000 description 2
• 229960002685 biotin Drugs 0.000 description 2
• 210000004369 blood Anatomy 0.000 description 2
• 239000008280 blood Substances 0.000 description 2
• 230000008499 blood brain barrier function Effects 0.000 description 2
• 210000001218 blood-brain barrier Anatomy 0.000 description 2
• 235000019835 bromelain Nutrition 0.000 description 2
• 201000011510 cancer Diseases 0.000 description 2
• 230000011712 cell development Effects 0.000 description 2
• 230000019522 cellular metabolic process Effects 0.000 description 2
• 230000015271 coagulation Effects 0.000 description 2
• 238000005345 coagulation Methods 0.000 description 2
• 108091036078 conserved sequence Proteins 0.000 description 2
• 239000013068 control sample Substances 0.000 description 2
• 238000005520 cutting process Methods 0.000 description 2
• 230000001461 cytolytic effect Effects 0.000 description 2
• OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
• SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
• SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 2
• 230000007423 decrease Effects 0.000 description 2
• 230000003247 decreasing effect Effects 0.000 description 2
• 230000002950 deficient Effects 0.000 description 2
• 238000001212 derivatisation Methods 0.000 description 2
• 238000013461 design Methods 0.000 description 2
• 230000018109 developmental process Effects 0.000 description 2
• 206010012601 diabetes mellitus Diseases 0.000 description 2
• 238000003745 diagnosis Methods 0.000 description 2
• 239000000032 diagnostic agent Substances 0.000 description 2
• 229940039227 diagnostic agent Drugs 0.000 description 2
• QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 2
• SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 2
• 238000009509 drug development Methods 0.000 description 2
• 238000002296 dynamic light scattering Methods 0.000 description 2
• 238000005538 encapsulation Methods 0.000 description 2
• 235000020776 essential amino acid Nutrition 0.000 description 2
• 239000003797 essential amino acid Substances 0.000 description 2
• 230000007717 exclusion Effects 0.000 description 2
• 238000001914 filtration Methods 0.000 description 2
• 238000004108 freeze drying Methods 0.000 description 2
• 108010051239 glutaminyl-tRNA synthetase Proteins 0.000 description 2
• 229960003180 glutathione Drugs 0.000 description 2
• 239000005090 green fluorescent protein Substances 0.000 description 2
• 230000011132 hemopoiesis Effects 0.000 description 2
• 239000000833 heterodimer Substances 0.000 description 2
• 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 2
• 210000005260 human cell Anatomy 0.000 description 2
• 230000002209 hydrophobic effect Effects 0.000 description 2
• 238000001597 immobilized metal affinity chromatography Methods 0.000 description 2
• 230000001900 immune effect Effects 0.000 description 2
• 210000000987 immune system Anatomy 0.000 description 2
• 230000002163 immunogen Effects 0.000 description 2
• 229940072221 immunoglobulins Drugs 0.000 description 2
• 230000001976 improved effect Effects 0.000 description 2
• 238000011065 in-situ storage Methods 0.000 description 2
• 238000010348 incorporation Methods 0.000 description 2
• 238000004255 ion exchange chromatography Methods 0.000 description 2
• 238000002372 labelling Methods 0.000 description 2
• 231100000636 lethal dose Toxicity 0.000 description 2
• 238000001638 lipofection Methods 0.000 description 2
• 210000005229 liver cell Anatomy 0.000 description 2
• 238000011068 loading method Methods 0.000 description 2
• 230000002132 lysosomal effect Effects 0.000 description 2
• 229920002521 macromolecule Polymers 0.000 description 2
• 238000012423 maintenance Methods 0.000 description 2
• 230000002503 metabolic effect Effects 0.000 description 2
• 229910052751 metal Inorganic materials 0.000 description 2
• 239000002184 metal Substances 0.000 description 2
• 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 2
• 244000005700 microbiome Species 0.000 description 2
• 108091005601 modified peptides Proteins 0.000 description 2
• 239000003607 modifier Substances 0.000 description 2
• 210000004897 n-terminal region Anatomy 0.000 description 2
• 210000000440 neutrophil Anatomy 0.000 description 2
• 229910052759 nickel Inorganic materials 0.000 description 2
• 238000007899 nucleic acid hybridization Methods 0.000 description 2
• 239000002777 nucleoside Substances 0.000 description 2
• 239000002751 oligonucleotide probe Substances 0.000 description 2
• 238000005457 optimization Methods 0.000 description 2
• 150000002894 organic compounds Chemical class 0.000 description 2
• 229940055729 papain Drugs 0.000 description 2
• 235000019834 papain Nutrition 0.000 description 2
• 230000036961 partial effect Effects 0.000 description 2
• 230000001717 pathogenic effect Effects 0.000 description 2
• 238000002823 phage display Methods 0.000 description 2
• 125000000405 phenylalanyl group Chemical group 0.000 description 2
• 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
• 230000026731 phosphorylation Effects 0.000 description 2
• 238000006366 phosphorylation reaction Methods 0.000 description 2
• 230000001766 physiological effect Effects 0.000 description 2
• 230000035790 physiological processes and functions Effects 0.000 description 2
• 230000008488 polyadenylation Effects 0.000 description 2
• 229920002451 polyvinyl alcohol Polymers 0.000 description 2
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
• 230000003389 potentiating effect Effects 0.000 description 2
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
• 108010042589 prolyl T RNA synthetase Proteins 0.000 description 2
• 238000001742 protein purification Methods 0.000 description 2
• 230000006337 proteolytic cleavage Effects 0.000 description 2
• 238000003127 radioimmunoassay Methods 0.000 description 2
• 238000007830 receptor-based assay Methods 0.000 description 2
• 238000010188 recombinant method Methods 0.000 description 2
• 238000011084 recovery Methods 0.000 description 2
• 230000002829 reductive effect Effects 0.000 description 2
• 108091008146 restriction endonucleases Proteins 0.000 description 2
• PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
• 238000002864 sequence alignment Methods 0.000 description 2
• 239000012679 serum free medium Substances 0.000 description 2
• 238000001542 size-exclusion chromatography Methods 0.000 description 2
• 239000011780 sodium chloride Substances 0.000 description 2
• 239000007790 solid phase Substances 0.000 description 2
• 125000001424 substituent group Chemical group 0.000 description 2
• 238000004114 suspension culture Methods 0.000 description 2
• ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 2
• MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 2
• 229960004072 thrombin Drugs 0.000 description 2
• 239000003053 toxin Substances 0.000 description 2
• 231100000765 toxin Toxicity 0.000 description 2
• 108700012359 toxins Proteins 0.000 description 2
• 238000012546 transfer Methods 0.000 description 2
• 239000001226 triphosphate Substances 0.000 description 2
• 235000011178 triphosphate Nutrition 0.000 description 2
• 108010032276 tyrosyl-glutamyl-tyrosyl-glutamic acid Proteins 0.000 description 2
• 241000701447 unidentified baculovirus Species 0.000 description 2
• 238000011144 upstream manufacturing Methods 0.000 description 2
• 239000013603 viral vector Substances 0.000 description 2
• 229920003169 water-soluble polymer Polymers 0.000 description 2
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
• TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
• WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 description 1
• UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 1
• RUFPHBVGCFYCNW-UHFFFAOYSA-N 1-naphthylamine Chemical compound C1=CC=C2C(N)=CC=CC2=C1 RUFPHBVGCFYCNW-UHFFFAOYSA-N 0.000 description 1
• OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
• SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 description 1
• MXHRCPNRJAMMIM-SHYZEUOFSA-N 2'-deoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-SHYZEUOFSA-N 0.000 description 1
• 150000003923 2,5-pyrrolediones Chemical class 0.000 description 1
• 102100027324 2-hydroxyacyl-CoA lyase 1 Human genes 0.000 description 1
• CUVGUPIVTLGRGI-UHFFFAOYSA-N 4-(3-phosphonopropyl)piperazine-2-carboxylic acid Chemical compound OC(=O)C1CN(CCCP(O)(O)=O)CCN1 CUVGUPIVTLGRGI-UHFFFAOYSA-N 0.000 description 1
• LKDMKWNDBAVNQZ-UHFFFAOYSA-N 4-[[1-[[1-[2-[[1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)NC(C)C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(C(=O)NC=1C=CC(=CC=1)[N+]([O-])=O)CC1=CC=CC=C1 LKDMKWNDBAVNQZ-UHFFFAOYSA-N 0.000 description 1
• XWHHYOYVRVGJJY-UHFFFAOYSA-N 4-fluorophenylalanine Chemical compound OC(=O)C(N)CC1=CC=C(F)C=C1 XWHHYOYVRVGJJY-UHFFFAOYSA-N 0.000 description 1
• IDLISIVVYLGCKO-UHFFFAOYSA-N 6-carboxy-4',5'-dichloro-2',7'-dimethoxyfluorescein Chemical compound O1C(=O)C2=CC=C(C(O)=O)C=C2C21C1=CC(OC)=C(O)C(Cl)=C1OC1=C2C=C(OC)C(O)=C1Cl IDLISIVVYLGCKO-UHFFFAOYSA-N 0.000 description 1
• UKLNSYRWDXRTER-UHFFFAOYSA-N 7-isocyanato-3-phenylchromen-2-one Chemical compound O=C1OC2=CC(N=C=O)=CC=C2C=C1C1=CC=CC=C1 UKLNSYRWDXRTER-UHFFFAOYSA-N 0.000 description 1
• FWEOQOXTVHGIFQ-UHFFFAOYSA-N 8-anilinonaphthalene-1-sulfonic acid Chemical compound C=12C(S(=O)(=O)O)=CC=CC2=CC=CC=1NC1=CC=CC=C1 FWEOQOXTVHGIFQ-UHFFFAOYSA-N 0.000 description 1
• NLSUMBWPPJUVST-UHFFFAOYSA-N 9-isothiocyanatoacridine Chemical compound C1=CC=C2C(N=C=S)=C(C=CC=C3)C3=NC2=C1 NLSUMBWPPJUVST-UHFFFAOYSA-N 0.000 description 1
• ZHQQRIUYLMXDPP-SSDOTTSWSA-N Actinidine Natural products C1=NC=C(C)C2=C1[C@H](C)CC2 ZHQQRIUYLMXDPP-SSDOTTSWSA-N 0.000 description 1
• 102100029457 Adenine phosphoribosyltransferase Human genes 0.000 description 1
• 108010024223 Adenine phosphoribosyltransferase Proteins 0.000 description 1
• 229920000936 Agarose Polymers 0.000 description 1
• 108010025188 Alcohol oxidase Proteins 0.000 description 1
• 239000012103 Alexa Fluor 488 Substances 0.000 description 1
• 239000012109 Alexa Fluor 568 Substances 0.000 description 1
• 239000012110 Alexa Fluor 594 Substances 0.000 description 1
• 239000012114 Alexa Fluor 647 Substances 0.000 description 1
• 239000012116 Alexa Fluor 680 Substances 0.000 description 1
• 239000012118 Alexa Fluor 750 Substances 0.000 description 1
• 239000012099 Alexa Fluor family Substances 0.000 description 1
• 102100022749 Aminopeptidase N Human genes 0.000 description 1
• 108090000915 Aminopeptidases Proteins 0.000 description 1
• 102000004400 Aminopeptidases Human genes 0.000 description 1
• 108010001779 Ancrod Proteins 0.000 description 1
• 235000002198 Annona diversifolia Nutrition 0.000 description 1
• 108700031308 Antennapedia Homeodomain Proteins 0.000 description 1
• 244000105975 Antidesma platyphyllum Species 0.000 description 1
• 108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
• OMLWNBVRVJYMBQ-YUMQZZPRSA-N Arg-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O OMLWNBVRVJYMBQ-YUMQZZPRSA-N 0.000 description 1
• JSLGXODUIAFWCF-WDSKDSINSA-N Arg-Asn Chemical group NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O JSLGXODUIAFWCF-WDSKDSINSA-N 0.000 description 1
• 208000002109 Argyria Diseases 0.000 description 1
• NPDLYUOYAGBHFB-WDSKDSINSA-N Asn-Arg Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCCN=C(N)N NPDLYUOYAGBHFB-WDSKDSINSA-N 0.000 description 1
• QCWJKJLNCFEVPQ-WHFBIAKZSA-N Asn-Gln Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O QCWJKJLNCFEVPQ-WHFBIAKZSA-N 0.000 description 1
• GHODABZPVZMWCE-FXQIFTODSA-N Asp-Glu-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O GHODABZPVZMWCE-FXQIFTODSA-N 0.000 description 1
• 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
• 240000006439 Aspergillus oryzae Species 0.000 description 1
• 241000228251 Aspergillus phoenicis Species 0.000 description 1
• 241000131386 Aspergillus sojae Species 0.000 description 1
• 108090000658 Astacin Proteins 0.000 description 1
• 102000034498 Astacin Human genes 0.000 description 1
• 241000972773 Aulopiformes Species 0.000 description 1
• 241000714235 Avian retrovirus Species 0.000 description 1
• 241000194108 Bacillus licheniformis Species 0.000 description 1
• 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 1
• 108010077805 Bacterial Proteins Proteins 0.000 description 1
• 102100026189 Beta-galactosidase Human genes 0.000 description 1
• 238000009010 Bradford assay Methods 0.000 description 1
• 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
• 108010049990 CD13 Antigens Proteins 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 241000282832 Camelidae Species 0.000 description 1
• 241000282465 Canis Species 0.000 description 1
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
• UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical class [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
• 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
• 108090000087 Carboxypeptidase B Proteins 0.000 description 1
• 102000003670 Carboxypeptidase B Human genes 0.000 description 1
• 108010080937 Carboxypeptidases A Proteins 0.000 description 1
• 102000000496 Carboxypeptidases A Human genes 0.000 description 1
• 108090000397 Caspase 3 Proteins 0.000 description 1
• 102000004018 Caspase 6 Human genes 0.000 description 1
• 108090000425 Caspase 6 Proteins 0.000 description 1
• 108090000567 Caspase 7 Proteins 0.000 description 1
• 108090000426 Caspase-1 Proteins 0.000 description 1
• 102000004068 Caspase-10 Human genes 0.000 description 1
• 108090000572 Caspase-10 Proteins 0.000 description 1
• 108090000570 Caspase-12 Proteins 0.000 description 1
• 102000004066 Caspase-12 Human genes 0.000 description 1
• 102100032616 Caspase-2 Human genes 0.000 description 1
• 108090000552 Caspase-2 Proteins 0.000 description 1
• 102100029855 Caspase-3 Human genes 0.000 description 1
• 102100025597 Caspase-4 Human genes 0.000 description 1
• 101710090338 Caspase-4 Proteins 0.000 description 1
• 102100038916 Caspase-5 Human genes 0.000 description 1
• 101710090333 Caspase-5 Proteins 0.000 description 1
• 102100038902 Caspase-7 Human genes 0.000 description 1
• 102100026548 Caspase-8 Human genes 0.000 description 1
• 108090000538 Caspase-8 Proteins 0.000 description 1
• 102000004039 Caspase-9 Human genes 0.000 description 1
• 108090000566 Caspase-9 Proteins 0.000 description 1
• 108090000712 Cathepsin B Proteins 0.000 description 1
• 102000004225 Cathepsin B Human genes 0.000 description 1
• 102000003902 Cathepsin C Human genes 0.000 description 1
• 108090000267 Cathepsin C Proteins 0.000 description 1
• 102000003908 Cathepsin D Human genes 0.000 description 1
• 108090000258 Cathepsin D Proteins 0.000 description 1
• 102000004178 Cathepsin E Human genes 0.000 description 1
• 108090000611 Cathepsin E Proteins 0.000 description 1
• 102000004173 Cathepsin G Human genes 0.000 description 1
• 108090000617 Cathepsin G Proteins 0.000 description 1
• 108090000619 Cathepsin H Proteins 0.000 description 1
• 102000004175 Cathepsin H Human genes 0.000 description 1
• 108090000624 Cathepsin L Proteins 0.000 description 1
• 102000004172 Cathepsin L Human genes 0.000 description 1
• 241000701489 Cauliflower mosaic virus Species 0.000 description 1
• 241000700199 Cavia porcellus Species 0.000 description 1
• 241001529572 Chaceon affinis Species 0.000 description 1
• 241000282552 Chlorocebus aethiops Species 0.000 description 1
• VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
• 102100024539 Chymase Human genes 0.000 description 1
• 108090000227 Chymases Proteins 0.000 description 1
• 108090001069 Chymopapain Proteins 0.000 description 1
• 108090000746 Chymosin Proteins 0.000 description 1
• 241000320892 Clerodendrum phlomidis Species 0.000 description 1
• 102000029816 Collagenase Human genes 0.000 description 1
• 108060005980 Collagenase Proteins 0.000 description 1
• 208000035473 Communicable disease Diseases 0.000 description 1
• 108010028774 Complement C1 Proteins 0.000 description 1
• 108010078044 Complement C1r Proteins 0.000 description 1
• 102100030149 Complement C1r subcomponent Human genes 0.000 description 1
• 102100025406 Complement C1s subcomponent Human genes 0.000 description 1
• 108090000044 Complement Factor I Proteins 0.000 description 1
• 102000003706 Complement factor D Human genes 0.000 description 1
• 108090000059 Complement factor D Proteins 0.000 description 1
• 102100035431 Complement factor I Human genes 0.000 description 1
• 108091029430 CpG site Proteins 0.000 description 1
• 241000699800 Cricetinae Species 0.000 description 1
• 241000699802 Cricetulus griseus Species 0.000 description 1
• MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
• 241000252867 Cupriavidus metallidurans Species 0.000 description 1
• 102000004127 Cytokines Human genes 0.000 description 1
• 108090000695 Cytokines Proteins 0.000 description 1
• IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
• NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
• 101150074155 DHFR gene Proteins 0.000 description 1
• 108091008102 DNA aptamers Proteins 0.000 description 1
• 230000009946 DNA mutation Effects 0.000 description 1
• 239000003155 DNA primer Substances 0.000 description 1
• 238000001712 DNA sequencing Methods 0.000 description 1
• 230000006820 DNA synthesis Effects 0.000 description 1
• 230000004568 DNA-binding Effects 0.000 description 1
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
• 101100239628 Danio rerio myca gene Proteins 0.000 description 1
• CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
• 241000702421 Dependoparvovirus Species 0.000 description 1
• 229920002307 Dextran Polymers 0.000 description 1
• FMKGDHLSXFDSOU-BDPUVYQTSA-N Dienon-Astacin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(=CC1(C)C)O)C=CC=C(/C)C=CC2=C(C)C(=O)C(=CC2(C)C)O FMKGDHLSXFDSOU-BDPUVYQTSA-N 0.000 description 1
• BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
• 102100025012 Dipeptidyl peptidase 4 Human genes 0.000 description 1
• 206010013883 Dwarfism Diseases 0.000 description 1
• 108700033921 EC 3.4.23.20 Proteins 0.000 description 1
• 208000017701 Endocrine disease Diseases 0.000 description 1
• 108010067770 Endopeptidase K Proteins 0.000 description 1
• 102100029727 Enteropeptidase Human genes 0.000 description 1
• 108010013369 Enteropeptidase Proteins 0.000 description 1
• 101710091045 Envelope protein Proteins 0.000 description 1
• 239000005977 Ethylene Substances 0.000 description 1
• 229910052693 Europium Inorganic materials 0.000 description 1
• 108050001049 Extracellular proteins Proteins 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• 108010088842 Fibrinolysin Proteins 0.000 description 1
• 108010067306 Fibronectins Proteins 0.000 description 1
• 108090000270 Ficain Proteins 0.000 description 1
• 229920001917 Ficoll Polymers 0.000 description 1
• 241000192125 Firmicutes Species 0.000 description 1
• BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
• 241000233866 Fungi Species 0.000 description 1
• 108090001126 Furin Proteins 0.000 description 1
• 102000004961 Furin Human genes 0.000 description 1
• 101000930822 Giardia intestinalis Dipeptidyl-peptidase 4 Proteins 0.000 description 1
• DXJZITDUDUPINW-WHFBIAKZSA-N Gln-Asn Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O DXJZITDUDUPINW-WHFBIAKZSA-N 0.000 description 1
• FYYSIASRLDJUNP-WHFBIAKZSA-N Glu-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O FYYSIASRLDJUNP-WHFBIAKZSA-N 0.000 description 1
• 102000053187 Glucuronidase Human genes 0.000 description 1
• 108010060309 Glucuronidase Proteins 0.000 description 1
• OOCFXNOVSLSHAB-IUCAKERBSA-N Gly-Pro-Pro Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 OOCFXNOVSLSHAB-IUCAKERBSA-N 0.000 description 1
• ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
• 229930186217 Glycolipid Natural products 0.000 description 1
• 108010010369 HIV Protease Proteins 0.000 description 1
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
• WSDOHRLQDGAOGU-BQBZGAKWSA-N His-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CN=CN1 WSDOHRLQDGAOGU-BQBZGAKWSA-N 0.000 description 1
• 101001009252 Homo sapiens 2-hydroxyacyl-CoA lyase 1 Proteins 0.000 description 1
• 108091006905 Human Serum Albumin Proteins 0.000 description 1
• 102000008100 Human Serum Albumin Human genes 0.000 description 1
• 229920001612 Hydroxyethyl starch Polymers 0.000 description 1
• LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 description 1
• PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
• 206010021143 Hypoxia Diseases 0.000 description 1
• UWBDLNOCIDGPQE-GUBZILKMSA-N Ile-Lys Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN UWBDLNOCIDGPQE-GUBZILKMSA-N 0.000 description 1
• 229910000673 Indium arsenide Inorganic materials 0.000 description 1
• GPXJNWSHGFTCBW-UHFFFAOYSA-N Indium phosphide Chemical compound [In]#P GPXJNWSHGFTCBW-UHFFFAOYSA-N 0.000 description 1
• 102000001399 Kallikrein Human genes 0.000 description 1
• 108060005987 Kallikrein Proteins 0.000 description 1
• 102100038297 Kallikrein-1 Human genes 0.000 description 1
• 101710176219 Kallikrein-1 Proteins 0.000 description 1
• SNDPXSYFESPGGJ-BYPYZUCNSA-N L-2-aminopentanoic acid Chemical compound CCC[C@H](N)C(O)=O SNDPXSYFESPGGJ-BYPYZUCNSA-N 0.000 description 1
• AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
• ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
• RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
• GGLZPLKKBSSKCX-YFKPBYRVSA-N L-ethionine Chemical compound CCSCC[C@H](N)C(O)=O GGLZPLKKBSSKCX-YFKPBYRVSA-N 0.000 description 1
• FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 1
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
• SNDPXSYFESPGGJ-UHFFFAOYSA-N L-norVal-OH Natural products CCCC(N)C(O)=O SNDPXSYFESPGGJ-UHFFFAOYSA-N 0.000 description 1
• LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 description 1
• 125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 description 1
• 125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 description 1
• 238000011050 LAL assay Methods 0.000 description 1
• 241000282838 Lama Species 0.000 description 1
• 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
• 241000239218 Limulus Species 0.000 description 1
• 102000019298 Lipocalin Human genes 0.000 description 1
• 108050006654 Lipocalin Proteins 0.000 description 1
• 241000186779 Listeria monocytogenes Species 0.000 description 1
• DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
• NPBGTPKLVJEOBE-IUCAKERBSA-N Lys-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N NPBGTPKLVJEOBE-IUCAKERBSA-N 0.000 description 1
• CIOWSLJGLSUOME-BQBZGAKWSA-N Lys-Asp Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O CIOWSLJGLSUOME-BQBZGAKWSA-N 0.000 description 1
• 101001018085 Lysobacter enzymogenes Lysyl endopeptidase Proteins 0.000 description 1
• GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
• 101100261636 Methanothermobacter marburgensis (strain ATCC BAA-927 / DSM 2133 / JCM 14651 / NBRC 100331 / OCM 82 / Marburg) trpB2 gene Proteins 0.000 description 1
• 101710181812 Methionine aminopeptidase Proteins 0.000 description 1
• 206010027626 Milia Diseases 0.000 description 1
• 241000204795 Muraena helena Species 0.000 description 1
• 101000933115 Mus musculus Caspase-4 Proteins 0.000 description 1
• 101100310393 Mus musculus Slk gene Proteins 0.000 description 1
• 208000021642 Muscular disease Diseases 0.000 description 1
• NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
• 230000004988 N-glycosylation Effects 0.000 description 1
• 108010049175 N-substituted Glycines Proteins 0.000 description 1
• 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
• RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
• 229930193140 Neomycin Natural products 0.000 description 1
• 102100028782 Neprilysin Human genes 0.000 description 1
• 108090000028 Neprilysin Proteins 0.000 description 1
• 239000000020 Nitrocellulose Substances 0.000 description 1
• 101710163270 Nuclease Proteins 0.000 description 1
• 108091005461 Nucleic proteins Chemical group 0.000 description 1
• 239000004677 Nylon Substances 0.000 description 1
• 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
• AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
• UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
• 241000283973 Oryctolagus cuniculus Species 0.000 description 1
• 238000012408 PCR amplification Methods 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 241000194105 Paenibacillus polymyxa Species 0.000 description 1
• 102000007079 Peptide Fragments Human genes 0.000 description 1
• 108010033276 Peptide Fragments Proteins 0.000 description 1
• 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 1
• 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 1
• 241001662443 Phemeranthus parviflorus Species 0.000 description 1
• 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
• 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
• 101100124346 Photorhabdus laumondii subsp. laumondii (strain DSM 15139 / CIP 105565 / TT01) hisCD gene Proteins 0.000 description 1
• 241000235648 Pichia Species 0.000 description 1
• 206010035226 Plasma cell myeloma Diseases 0.000 description 1
• 241000276498 Pollachius virens Species 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• HAAQQNHQZBOWFO-LURJTMIESA-N Pro-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1 HAAQQNHQZBOWFO-LURJTMIESA-N 0.000 description 1
• 108010059712 Pronase Proteins 0.000 description 1
• 108010072866 Prostate-Specific Antigen Proteins 0.000 description 1
• 102100038358 Prostate-specific antigen Human genes 0.000 description 1
• 101800001753 Protease Proteins 0.000 description 1
• 101800004937 Protein C Proteins 0.000 description 1
• 102000017975 Protein C Human genes 0.000 description 1
• 101710149951 Protein Tat Proteins 0.000 description 1
• 101710188315 Protein X Proteins 0.000 description 1
• 108010026552 Proteome Proteins 0.000 description 1
• 206010037660 Pyrexia Diseases 0.000 description 1
• 108090000919 Pyroglutamyl-Peptidase I Proteins 0.000 description 1
• 108020004518 RNA Probes Proteins 0.000 description 1
• 108091008103 RNA aptamers Proteins 0.000 description 1
• 239000003391 RNA probe Substances 0.000 description 1
• 230000004570 RNA-binding Effects 0.000 description 1
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
• 241000700159 Rattus Species 0.000 description 1
• 241000700157 Rattus norvegicus Species 0.000 description 1
• 101001091368 Rattus norvegicus Glandular kallikrein-7, submandibular/renal Proteins 0.000 description 1
• 206010062237 Renal impairment Diseases 0.000 description 1
• 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
• 241000952054 Rhizopus sp. Species 0.000 description 1
• 108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 description 1
• 101000898773 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Saccharopepsin Proteins 0.000 description 1
• 101800001700 Saposin-D Proteins 0.000 description 1
• 241000242678 Schistosoma Species 0.000 description 1
• 108010034546 Serratia marcescens nuclease Proteins 0.000 description 1
• XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
• 241000700584 Simplexvirus Species 0.000 description 1
• 229930182558 Sterol Natural products 0.000 description 1
• PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
• 108010090804 Streptavidin Proteins 0.000 description 1
• 108010023197 Streptokinase Proteins 0.000 description 1
• 241000187392 Streptomyces griseus Species 0.000 description 1
• 108010056079 Subtilisins Proteins 0.000 description 1
• 102000005158 Subtilisins Human genes 0.000 description 1
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
• 101710137500 T7 RNA polymerase Proteins 0.000 description 1
• 108091046869 Telomeric non-coding RNA Proteins 0.000 description 1
• DSGIVWSDDRDJIO-ZXXMMSQZSA-N Thr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O DSGIVWSDDRDJIO-ZXXMMSQZSA-N 0.000 description 1
• 108091036066 Three prime untranslated region Proteins 0.000 description 1
• 108020004440 Thymidine kinase Proteins 0.000 description 1
• ISWQCIVKKSOKNN-UHFFFAOYSA-L Tiron Chemical compound [Na+].[Na+].OC1=CC(S([O-])(=O)=O)=CC(S([O-])(=O)=O)=C1O ISWQCIVKKSOKNN-UHFFFAOYSA-L 0.000 description 1
• 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 1
• 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 1
• 102000040945 Transcription factor Human genes 0.000 description 1
• 108091023040 Transcription factor Proteins 0.000 description 1
• 108020004566 Transfer RNA Proteins 0.000 description 1
• 102000004338 Transferrin Human genes 0.000 description 1
• 108090000901 Transferrin Proteins 0.000 description 1
• GDPDVIBHJDFRFD-RNXOBYDBSA-N Trp-Tyr-Tyr Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O GDPDVIBHJDFRFD-RNXOBYDBSA-N 0.000 description 1
• 241000223104 Trypanosoma Species 0.000 description 1
• 102000001400 Tryptase Human genes 0.000 description 1
• 108060005989 Tryptase Proteins 0.000 description 1
• 102100034300 Tryptophan-tRNA ligase, cytoplasmic Human genes 0.000 description 1
• 102220474825 Tryptophan-tRNA ligase, cytoplasmic_A54S_mutation Human genes 0.000 description 1
• BMPPMAOOKQJYIP-WMZOPIPTSA-N Tyr-Trp Chemical compound C([C@H]([NH3+])C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C([O-])=O)C1=CC=C(O)C=C1 BMPPMAOOKQJYIP-WMZOPIPTSA-N 0.000 description 1
• 108090000848 Ubiquitin Proteins 0.000 description 1
• 102000044159 Ubiquitin Human genes 0.000 description 1
• 101710100170 Unknown protein Proteins 0.000 description 1
• 108091023045 Untranslated Region Proteins 0.000 description 1
• DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 1
• 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
• 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
• 206010046865 Vaccinia virus infection Diseases 0.000 description 1
• 244000000188 Vaccinium ovalifolium Species 0.000 description 1
• PNVLWFYAPWAQMU-CIUDSAMLSA-N Val-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)C(C)C PNVLWFYAPWAQMU-CIUDSAMLSA-N 0.000 description 1
• WBAJDGWKRIHOAC-GVXVVHGQSA-N Val-Lys-Gln Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O WBAJDGWKRIHOAC-GVXVVHGQSA-N 0.000 description 1
• ZVNYJIZDIRKMBF-UHFFFAOYSA-N Vesnarinone Chemical compound C1=C(OC)C(OC)=CC=C1C(=O)N1CCN(C=2C=C3CCC(=O)NC3=CC=2)CC1 ZVNYJIZDIRKMBF-UHFFFAOYSA-N 0.000 description 1
• IXKSXJFAGXLQOQ-XISFHERQSA-N WHWLQLKPGQPMY Chemical compound C([C@@H](C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CNC=N1 IXKSXJFAGXLQOQ-XISFHERQSA-N 0.000 description 1
• 208000027418 Wounds and injury Diseases 0.000 description 1
• 102100039662 Xaa-Pro dipeptidase Human genes 0.000 description 1
• DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 1
• ZHQQRIUYLMXDPP-ZETCQYMHSA-N actinidine Chemical compound C1=NC=C(C)C2=C1[C@@H](C)CC2 ZHQQRIUYLMXDPP-ZETCQYMHSA-N 0.000 description 1
• 230000010933 acylation Effects 0.000 description 1
• 238000005917 acylation reaction Methods 0.000 description 1
• 229960005305 adenosine Drugs 0.000 description 1
• 150000003838 adenosines Chemical class 0.000 description 1
• 230000011759 adipose tissue development Effects 0.000 description 1
• 238000001042 affinity chromatography Methods 0.000 description 1
• 125000001931 aliphatic group Chemical group 0.000 description 1
• 230000009435 amidation Effects 0.000 description 1
• 238000007112 amidation reaction Methods 0.000 description 1
• 125000003277 amino group Chemical group 0.000 description 1
• 229940126575 aminoglycoside Drugs 0.000 description 1
• 238000012801 analytical assay Methods 0.000 description 1
• 229960004233 ancrod Drugs 0.000 description 1
• 208000007502 anemia Diseases 0.000 description 1
• 229940125365 angiotensin receptor blocker-neprilysin inhibitor Drugs 0.000 description 1
• 125000000129 anionic group Chemical group 0.000 description 1
• 239000004410 anthocyanin Substances 0.000 description 1
• 235000010208 anthocyanin Nutrition 0.000 description 1
• 229930002877 anthocyanin Natural products 0.000 description 1
• 150000004636 anthocyanins Chemical class 0.000 description 1
• 230000000340 anti-metabolite Effects 0.000 description 1
• 229940088710 antibiotic agent Drugs 0.000 description 1
• 239000002256 antimetabolite Substances 0.000 description 1
• 229940100197 antimetabolite Drugs 0.000 description 1
• 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
• 108010068380 arginylarginine Proteins 0.000 description 1
• 229940009098 aspartate Drugs 0.000 description 1
• 235000003676 astacin Nutrition 0.000 description 1
• 210000001130 astrocyte Anatomy 0.000 description 1
• 238000000376 autoradiography Methods 0.000 description 1
• 210000003719 b-lymphocyte Anatomy 0.000 description 1
• 210000003651 basophil Anatomy 0.000 description 1
• 239000011324 bead Substances 0.000 description 1
• 230000006399 behavior Effects 0.000 description 1
• 229940049706 benzodiazepine Drugs 0.000 description 1
• 108010005774 beta-Galactosidase Proteins 0.000 description 1
• DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
• 125000003164 beta-aspartyl group Chemical group 0.000 description 1
• GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
• 230000001588 bifunctional effect Effects 0.000 description 1
• 230000000975 bioactive effect Effects 0.000 description 1
• 230000003115 biocidal effect Effects 0.000 description 1
• 239000003124 biologic agent Substances 0.000 description 1
• 239000012472 biological sample Substances 0.000 description 1
• 229960000074 biopharmaceutical Drugs 0.000 description 1
• 229920001222 biopolymer Polymers 0.000 description 1
• 210000000601 blood cell Anatomy 0.000 description 1
• 230000036772 blood pressure Effects 0.000 description 1
• 210000001124 body fluid Anatomy 0.000 description 1
• 239000010839 body fluid Substances 0.000 description 1
• 230000036760 body temperature Effects 0.000 description 1
• 230000037396 body weight Effects 0.000 description 1
• 210000001185 bone marrow Anatomy 0.000 description 1
• 238000009395 breeding Methods 0.000 description 1
• 230000001488 breeding effect Effects 0.000 description 1
• UHYPYGJEEGLRJD-UHFFFAOYSA-N cadmium(2+);selenium(2-) Chemical compound [Se-2].[Cd+2] UHYPYGJEEGLRJD-UHFFFAOYSA-N 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 238000004364 calculation method Methods 0.000 description 1
• 125000004432 carbon atom Chemical group C* 0.000 description 1
• 229910002090 carbon oxide Inorganic materials 0.000 description 1
• 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
• 239000001768 carboxy methyl cellulose Substances 0.000 description 1
• 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
• 230000021523 carboxylation Effects 0.000 description 1
• 238000006473 carboxylation reaction Methods 0.000 description 1
• 150000001735 carboxylic acids Chemical class 0.000 description 1
• 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
• 108010054847 carboxypeptidase P Proteins 0.000 description 1
• 108010018550 caspase 13 Proteins 0.000 description 1
• 230000003197 catalytic effect Effects 0.000 description 1
• 125000002091 cationic group Chemical group 0.000 description 1
• 230000010261 cell growth Effects 0.000 description 1
• 230000006037 cell lysis Effects 0.000 description 1
• 230000036755 cellular response Effects 0.000 description 1
• 230000004700 cellular uptake Effects 0.000 description 1
• 210000003169 central nervous system Anatomy 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• 239000000919 ceramic Substances 0.000 description 1
• 208000019065 cervical carcinoma Diseases 0.000 description 1
• 239000013043 chemical agent Substances 0.000 description 1
• 125000003636 chemical group Chemical group 0.000 description 1
• 238000007385 chemical modification Methods 0.000 description 1
• 210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
• 229910052804 chromium Inorganic materials 0.000 description 1
• 239000011651 chromium Substances 0.000 description 1
• 210000000349 chromosome Anatomy 0.000 description 1
• 229960002976 chymopapain Drugs 0.000 description 1
• 229940080701 chymosin Drugs 0.000 description 1
• 229960002173 citrulline Drugs 0.000 description 1
• 235000013477 citrulline Nutrition 0.000 description 1
• 238000003776 cleavage reaction Methods 0.000 description 1
• 108090001092 clostripain Proteins 0.000 description 1
• 229910017052 cobalt Inorganic materials 0.000 description 1
• 239000010941 cobalt Substances 0.000 description 1
• GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
• 229960002424 collagenase Drugs 0.000 description 1
• 238000004440 column chromatography Methods 0.000 description 1
• 238000002742 combinatorial mutagenesis Methods 0.000 description 1
• 239000012141 concentrate Substances 0.000 description 1
• 230000021615 conjugation Effects 0.000 description 1
• 239000000470 constituent Substances 0.000 description 1
• 238000010276 construction Methods 0.000 description 1
• 238000012926 crystallographic analysis Methods 0.000 description 1
• 108090000200 cucumisin Proteins 0.000 description 1
• 238000012258 culturing Methods 0.000 description 1
• 229940104302 cytosine Drugs 0.000 description 1
• 210000000172 cytosol Anatomy 0.000 description 1
• 230000006378 damage Effects 0.000 description 1
• 230000007812 deficiency Effects 0.000 description 1
• 239000007857 degradation product Substances 0.000 description 1
• 230000003111 delayed effect Effects 0.000 description 1
• YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
• 210000004443 dendritic cell Anatomy 0.000 description 1
• 239000005547 deoxyribonucleotide Substances 0.000 description 1
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
• 230000001419 dependent effect Effects 0.000 description 1
• 238000011082 depyrogenation Methods 0.000 description 1
• 230000003831 deregulation Effects 0.000 description 1
• MXHRCPNRJAMMIM-UHFFFAOYSA-N desoxyuridine Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-UHFFFAOYSA-N 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• 235000005911 diet Nutrition 0.000 description 1
• 230000037213 diet Effects 0.000 description 1
• 108091007734 digestive enzymes Proteins 0.000 description 1
• 102000038379 digestive enzymes Human genes 0.000 description 1
• XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
• 235000011180 diphosphates Nutrition 0.000 description 1
• 208000016097 disease of metabolism Diseases 0.000 description 1
• 238000010494 dissociation reaction Methods 0.000 description 1
• 230000005593 dissociations Effects 0.000 description 1
• PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
• 239000003937 drug carrier Substances 0.000 description 1
• 238000009510 drug design Methods 0.000 description 1
• 238000007877 drug screening Methods 0.000 description 1
• 238000001035 drying Methods 0.000 description 1
• 241001493065 dsRNA viruses Species 0.000 description 1
• 230000002526 effect on cardiovascular system Effects 0.000 description 1
• 239000012636 effector Substances 0.000 description 1
• 238000004520 electroporation Methods 0.000 description 1
• 238000010828 elution Methods 0.000 description 1
• 108010003914 endoproteinase Asp-N Proteins 0.000 description 1
• 230000002708 enhancing effect Effects 0.000 description 1
• 238000007824 enzymatic assay Methods 0.000 description 1
• 210000003979 eosinophil Anatomy 0.000 description 1
• 230000008029 eradication Effects 0.000 description 1
• YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 description 1
• 230000032050 esterification Effects 0.000 description 1
• 238000005886 esterification reaction Methods 0.000 description 1
• 150000002148 esters Chemical class 0.000 description 1
• OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 1
• 230000005284 excitation Effects 0.000 description 1
• 210000000887 face Anatomy 0.000 description 1
• 238000000855 fermentation Methods 0.000 description 1
• 230000004151 fermentation Effects 0.000 description 1
• 230000001605 fetal effect Effects 0.000 description 1
• 235000019836 ficin Nutrition 0.000 description 1
• POTUGHMKJGOKRI-UHFFFAOYSA-N ficin Chemical compound FI=CI=N POTUGHMKJGOKRI-UHFFFAOYSA-N 0.000 description 1
• 238000002866 fluorescence resonance energy transfer Methods 0.000 description 1
• 239000003269 fluorescent indicator Substances 0.000 description 1
• 108091006047 fluorescent proteins Proteins 0.000 description 1
• 102000034287 fluorescent proteins Human genes 0.000 description 1
• 238000009472 formulation Methods 0.000 description 1
• 238000013467 fragmentation Methods 0.000 description 1
• 238000006062 fragmentation reaction Methods 0.000 description 1
• 230000002538 fungal effect Effects 0.000 description 1
• 108010062699 gamma-Glutamyl Hydrolase Proteins 0.000 description 1
• 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 1
• 239000007789 gas Substances 0.000 description 1
• 239000000499 gel Substances 0.000 description 1
• 238000002523 gelfiltration Methods 0.000 description 1
• 102000034356 gene-regulatory proteins Human genes 0.000 description 1
• 108091006104 gene-regulatory proteins Proteins 0.000 description 1
• 238000010353 genetic engineering Methods 0.000 description 1
• 239000011521 glass Substances 0.000 description 1
• 229930195712 glutamate Natural products 0.000 description 1
• 150000004676 glycans Chemical class 0.000 description 1
• 150000002313 glycerolipids Chemical class 0.000 description 1
• 150000002314 glycerols Chemical class 0.000 description 1
• 150000002333 glycines Chemical class 0.000 description 1
• 150000002334 glycols Chemical class 0.000 description 1
• 230000013595 glycosylation Effects 0.000 description 1
• 238000006206 glycosylation reaction Methods 0.000 description 1
• 239000001963 growth medium Substances 0.000 description 1
• 229940029575 guanosine Drugs 0.000 description 1
• 235000009424 haa Nutrition 0.000 description 1
• 230000003394 haemopoietic effect Effects 0.000 description 1
• 235000015220 hamburgers Nutrition 0.000 description 1
• 208000014951 hematologic disease Diseases 0.000 description 1
• 230000002489 hematologic effect Effects 0.000 description 1
• 229960002897 heparin Drugs 0.000 description 1
• 229920000669 heparin Polymers 0.000 description 1
• 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
• 210000003494 hepatocyte Anatomy 0.000 description 1
• 239000004009 herbicide Substances 0.000 description 1
• 101150113423 hisD gene Proteins 0.000 description 1
• 239000012456 homogeneous solution Substances 0.000 description 1
• 229940088597 hormone Drugs 0.000 description 1
• 239000005556 hormone Substances 0.000 description 1
• 229920001477 hydrophilic polymer Polymers 0.000 description 1
• QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 description 1
• 229940050526 hydroxyethylstarch Drugs 0.000 description 1
• 230000033444 hydroxylation Effects 0.000 description 1
• 238000005805 hydroxylation reaction Methods 0.000 description 1
• 229960002591 hydroxyproline Drugs 0.000 description 1
• 230000007954 hypoxia Effects 0.000 description 1
• 210000002865 immune cell Anatomy 0.000 description 1
• 230000028993 immune response Effects 0.000 description 1
• 238000003018 immunoassay Methods 0.000 description 1
• 238000003119 immunoblot Methods 0.000 description 1
• 230000016784 immunoglobulin production Effects 0.000 description 1
• 210000003000 inclusion body Anatomy 0.000 description 1
• RPQDHPTXJYYUPQ-UHFFFAOYSA-N indium arsenide Chemical compound [In]#[As] RPQDHPTXJYYUPQ-UHFFFAOYSA-N 0.000 description 1
• PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
• RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
• 239000000411 inducer Substances 0.000 description 1
• 230000002458 infectious effect Effects 0.000 description 1
• 239000003112 inhibitor Substances 0.000 description 1
• 239000007924 injection Substances 0.000 description 1
• 238000002347 injection Methods 0.000 description 1
• 208000014674 injury Diseases 0.000 description 1
• 238000007689 inspection Methods 0.000 description 1
• 239000000543 intermediate Substances 0.000 description 1
• 230000008863 intramolecular interaction Effects 0.000 description 1
• RGXCTRIQQODGIZ-UHFFFAOYSA-O isodesmosine Chemical compound OC(=O)C(N)CCCC[N+]1=CC(CCC(N)C(O)=O)=CC(CCC(N)C(O)=O)=C1CCCC(N)C(O)=O RGXCTRIQQODGIZ-UHFFFAOYSA-O 0.000 description 1
• BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
• 230000000155 isotopic effect Effects 0.000 description 1
• 101150066555 lacZ gene Proteins 0.000 description 1
• 150000002605 large molecules Chemical class 0.000 description 1
• 239000010410 layer Substances 0.000 description 1
• 231100000518 lethal Toxicity 0.000 description 1
• 230000001665 lethal effect Effects 0.000 description 1
• 231100000225 lethality Toxicity 0.000 description 1
• 210000000265 leukocyte Anatomy 0.000 description 1
• 230000029226 lipidation Effects 0.000 description 1
• 239000007788 liquid Substances 0.000 description 1
• 238000004811 liquid chromatography Methods 0.000 description 1
• 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
• 210000004185 liver Anatomy 0.000 description 1
• 208000019423 liver disease Diseases 0.000 description 1
• 230000004807 localization Effects 0.000 description 1
• 230000007774 longterm Effects 0.000 description 1
• 210000005265 lung cell Anatomy 0.000 description 1
• 239000006166 lysate Substances 0.000 description 1
• 108010003700 lysyl aspartic acid Proteins 0.000 description 1
• 229920001427 mPEG Polymers 0.000 description 1
• 239000006249 magnetic particle Substances 0.000 description 1
• 238000013507 mapping Methods 0.000 description 1
• 238000001819 mass spectrum Methods 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 238000002844 melting Methods 0.000 description 1
• 230000008018 melting Effects 0.000 description 1
• 210000002901 mesenchymal stem cell Anatomy 0.000 description 1
• 208000030159 metabolic disease Diseases 0.000 description 1
• 230000004060 metabolic process Effects 0.000 description 1
• 229910021645 metal ion Inorganic materials 0.000 description 1
• 229960000485 methotrexate Drugs 0.000 description 1
• 230000011987 methylation Effects 0.000 description 1
• 238000007069 methylation reaction Methods 0.000 description 1
• 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
• 108010009355 microbial metalloproteinases Proteins 0.000 description 1
• 230000003228 microsomal effect Effects 0.000 description 1
• 230000005012 migration Effects 0.000 description 1
• 238000013508 migration Methods 0.000 description 1
• 230000003278 mimic effect Effects 0.000 description 1
• 210000003470 mitochondria Anatomy 0.000 description 1
• 230000002438 mitochondrial effect Effects 0.000 description 1
• 230000037230 mobility Effects 0.000 description 1
• 230000004001 molecular interaction Effects 0.000 description 1
• 210000001616 monocyte Anatomy 0.000 description 1
• 238000010172 mouse model Methods 0.000 description 1
• 238000002887 multiple sequence alignment Methods 0.000 description 1
• 230000003387 muscular Effects 0.000 description 1
• 201000000050 myeloid neoplasm Diseases 0.000 description 1
• 210000003643 myeloid progenitor cell Anatomy 0.000 description 1
• GNOLWGAJQVLBSM-UHFFFAOYSA-N n,n,5,7-tetramethyl-1,2,3,4-tetrahydronaphthalen-1-amine Chemical compound C1=C(C)C=C2C(N(C)C)CCCC2=C1C GNOLWGAJQVLBSM-UHFFFAOYSA-N 0.000 description 1
• 229960004927 neomycin Drugs 0.000 description 1
• 230000001613 neoplastic effect Effects 0.000 description 1
• 230000001537 neural effect Effects 0.000 description 1
• 230000000626 neurodegenerative effect Effects 0.000 description 1
• 230000004766 neurogenesis Effects 0.000 description 1
• 230000000926 neurological effect Effects 0.000 description 1
• 201000001119 neuropathy Diseases 0.000 description 1
• 230000007823 neuropathy Effects 0.000 description 1
• 150000002825 nitriles Chemical class 0.000 description 1
• 229920001220 nitrocellulos Polymers 0.000 description 1
• 108091027963 non-coding RNA Proteins 0.000 description 1
• 102000042567 non-coding RNA Human genes 0.000 description 1
• 210000000633 nuclear envelope Anatomy 0.000 description 1
• 125000003835 nucleoside group Chemical group 0.000 description 1
• 102000026415 nucleotide binding proteins Human genes 0.000 description 1
• 108091014756 nucleotide binding proteins Proteins 0.000 description 1
• 229920001778 nylon Polymers 0.000 description 1
• 230000009965 odorless effect Effects 0.000 description 1
• 229920001542 oligosaccharide Polymers 0.000 description 1
• 108010003052 omptin outer membrane protease Proteins 0.000 description 1
• 230000003287 optical effect Effects 0.000 description 1
• 150000007524 organic acids Chemical class 0.000 description 1
• 239000003960 organic solvent Substances 0.000 description 1
• 229960003104 ornithine Drugs 0.000 description 1
• 230000011164 ossification Effects 0.000 description 1
• 210000001672 ovary Anatomy 0.000 description 1
• 230000002018 overexpression Effects 0.000 description 1
• 210000000496 pancreas Anatomy 0.000 description 1
• 230000003071 parasitic effect Effects 0.000 description 1
• 244000052769 pathogen Species 0.000 description 1
• 230000007170 pathology Effects 0.000 description 1
• 230000037361 pathway Effects 0.000 description 1
• 230000035515 penetration Effects 0.000 description 1
• 208000033808 peripheral neuropathy Diseases 0.000 description 1
• 108040007629 peroxidase activity proteins Proteins 0.000 description 1
• 102000013415 peroxidase activity proteins Human genes 0.000 description 1
• 239000000546 pharmaceutical excipient Substances 0.000 description 1
• 230000010363 phase shift Effects 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
• 108010082527 phosphinothricin N-acetyltransferase Proteins 0.000 description 1
• 150000003904 phospholipids Chemical class 0.000 description 1
• 230000001817 pituitary effect Effects 0.000 description 1
• 230000036470 plasma concentration Effects 0.000 description 1
• 229940012957 plasmin Drugs 0.000 description 1
• 229920000724 poly(L-arginine) polymer Polymers 0.000 description 1
• 229920000233 poly(alkylene oxides) Polymers 0.000 description 1
• 229920001308 poly(aminoacid) Polymers 0.000 description 1
• 229920001583 poly(oxyethylated polyols) Polymers 0.000 description 1
• 108010011110 polyarginine Proteins 0.000 description 1
• 229920002704 polyhistidine Polymers 0.000 description 1
• 238000006116 polymerization reaction Methods 0.000 description 1
• 229920001451 polypropylene glycol Polymers 0.000 description 1
• 229920001282 polysaccharide Polymers 0.000 description 1
• 239000005017 polysaccharide Substances 0.000 description 1
• 230000036515 potency Effects 0.000 description 1
• 210000000229 preadipocyte Anatomy 0.000 description 1
• 238000001556 precipitation Methods 0.000 description 1
• 239000012602 primary packaging material Substances 0.000 description 1
• 210000001236 prokaryotic cell Anatomy 0.000 description 1
• 230000009465 prokaryotic expression Effects 0.000 description 1
• 108010066823 proline dipeptidase Proteins 0.000 description 1
• 108010020755 prolyl-glycyl-glycine Proteins 0.000 description 1
• 108010043535 protease S Proteins 0.000 description 1
• 230000004845 protein aggregation Effects 0.000 description 1
• 229960000856 protein c Drugs 0.000 description 1
• 108020001580 protein domains Proteins 0.000 description 1
• 238000000751 protein extraction Methods 0.000 description 1
• 239000012460 protein solution Substances 0.000 description 1
• 239000000985 reactive dye Substances 0.000 description 1
• 230000006798 recombination Effects 0.000 description 1
• 108091006091 regulatory enzymes Proteins 0.000 description 1
• 230000008439 repair process Effects 0.000 description 1
• 230000010076 replication Effects 0.000 description 1
• 108090000588 rhizopuspepsin Proteins 0.000 description 1
• 210000003705 ribosome Anatomy 0.000 description 1
• 102210062280 rs941923 Human genes 0.000 description 1
• 235000019515 salmon Nutrition 0.000 description 1
• 230000007017 scission Effects 0.000 description 1
• 238000012216 screening Methods 0.000 description 1
• 238000007423 screening assay Methods 0.000 description 1
• 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 1
• 229930000044 secondary metabolite Natural products 0.000 description 1
• 230000018448 secretion by cell Effects 0.000 description 1
• 238000010187 selection method Methods 0.000 description 1
• 239000006152 selective media Substances 0.000 description 1
• SBIBMFFZSBJNJF-UHFFFAOYSA-N selenium;zinc Chemical compound [Se]=[Zn] SBIBMFFZSBJNJF-UHFFFAOYSA-N 0.000 description 1
• 239000004065 semiconductor Substances 0.000 description 1
• 230000000405 serological effect Effects 0.000 description 1
• 210000000717 sertoli cell Anatomy 0.000 description 1
• 239000004017 serum-free culture medium Substances 0.000 description 1
• 230000035939 shock Effects 0.000 description 1
• 230000037432 silent mutation Effects 0.000 description 1
• 229910052710 silicon Inorganic materials 0.000 description 1
• 239000010703 silicon Substances 0.000 description 1
• 210000002363 skeletal muscle cell Anatomy 0.000 description 1
• 230000022379 skeletal muscle tissue development Effects 0.000 description 1
• 239000011734 sodium Substances 0.000 description 1
• 239000001509 sodium citrate Substances 0.000 description 1
• NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
• 239000001488 sodium phosphate Substances 0.000 description 1
• 229910000162 sodium phosphate Inorganic materials 0.000 description 1
• 239000007787 solid Substances 0.000 description 1
• 238000010532 solid phase synthesis reaction Methods 0.000 description 1
• 238000001179 sorption measurement Methods 0.000 description 1
• 125000006850 spacer group Chemical group 0.000 description 1
• 238000001228 spectrum Methods 0.000 description 1
• 230000010473 stable expression Effects 0.000 description 1
• 238000010186 staining Methods 0.000 description 1
• 210000000130 stem cell Anatomy 0.000 description 1
• 150000003431 steroids Chemical class 0.000 description 1
• 150000003432 sterols Chemical class 0.000 description 1
• 235000003702 sterols Nutrition 0.000 description 1
• PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
• 235000021286 stilbenes Nutrition 0.000 description 1
• 229960005202 streptokinase Drugs 0.000 description 1
• 230000035882 stress Effects 0.000 description 1
• 235000000346 sugar Nutrition 0.000 description 1
• 229910052717 sulfur Inorganic materials 0.000 description 1
• 239000011593 sulfur Substances 0.000 description 1
• 239000013589 supplement Substances 0.000 description 1
• 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 1
• 230000004083 survival effect Effects 0.000 description 1
• 238000001308 synthesis method Methods 0.000 description 1
• 230000002194 synthesizing effect Effects 0.000 description 1
• 150000003573 thiols Chemical class 0.000 description 1
• 238000012090 tissue culture technique Methods 0.000 description 1
• 229960000187 tissue plasminogen activator Drugs 0.000 description 1
• 230000001988 toxicity Effects 0.000 description 1
• 231100000419 toxicity Toxicity 0.000 description 1
• 238000001890 transfection Methods 0.000 description 1
• 238000003151 transfection method Methods 0.000 description 1
• 239000012581 transferrin Substances 0.000 description 1
• 230000009261 transgenic effect Effects 0.000 description 1
• RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
• 101150081616 trpB gene Proteins 0.000 description 1
• 101150111232 trpB-1 gene Proteins 0.000 description 1
• 229960001322 trypsin Drugs 0.000 description 1
• 125000005454 tryptophanyl group Chemical group 0.000 description 1
• 238000000108 ultra-filtration Methods 0.000 description 1
• 241001529453 unidentified herpesvirus Species 0.000 description 1
• 241001515965 unidentified phage Species 0.000 description 1
• DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
• 229940045145 uridine Drugs 0.000 description 1
• 229960005356 urokinase Drugs 0.000 description 1
• 208000007089 vaccinia Diseases 0.000 description 1
• 229940088594 vitamin Drugs 0.000 description 1
• 235000013343 vitamin Nutrition 0.000 description 1
• 239000011782 vitamin Substances 0.000 description 1
• 229930003231 vitamin Natural products 0.000 description 1
• 239000003643 water by type Substances 0.000 description 1
• 238000001262 western blot Methods 0.000 description 1
• 239000001018 xanthene dye Substances 0.000 description 1
• 230000004572 zinc-binding Effects 0.000 description 1